Design and optimization of peptidomimetics as PD-1/PD-L1 modulators for the management of triple-negative breast cancer

In Silico Pharmacology 2026 Open access

Read full text
Authors: HemaNandini Rajendran Krishnamoorthy, Ramanathan Karuppasamy
DOI: 10.1007/s40203-025-00528-w
Cited by: 0
References: 40

Fields of Study & Subjects

Peptidase Inhibition and Analysis Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies

Publication details

Journal / source
In Silico Pharmacology
Volume
14
Issue
1
Pages
20–20
Publication date
8 January 2026
Language
EN